CDLX 📈 Cardlytics - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14161W1053
CDLX: Advertising, Analytics, Data, Marketing, Platform
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Web URL: https://www.cardlytics.com
Additional Sources for CDLX Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CDLX Stock Overview
| Market Cap in USD | 190m |
| Sector | Communication Services |
| Industry | Advertising Agencies |
| GiC Sub-Industry | Advertising |
| IPO / Inception | 2018-02-09 |
CDLX Stock Ratings
| Growth 5y | -88.7% |
| Fundamental | -17.7% |
| Dividend | - |
| Rel. Strength Industry | -263 |
| Analysts | 2.83/5 |
| Fair Price Momentum | 2.07 USD |
| Fair Price DCF | - |
CDLX Dividends
No Dividends PaidCDLX Growth Ratios
| Growth Correlation 3m | 19% |
| Growth Correlation 12m | -62.9% |
| Growth Correlation 5y | -80.9% |
| CAGR 5y | -42.83% |
| CAGR/Mean DD 5y | -0.65 |
| Sharpe Ratio 12m | 0.04 |
| Alpha | -120.68 |
| Beta | 2.54 |
| Volatility | 92.91% |
| Current Volume | 1411.1k |
| Average Volume 20d | 742.7k |
What is the price of CDLX stocks?
As of December 30, 2024, the stock is trading at USD 3.73 with a total of 1,411,056 shares traded.
Over the past week, the price has changed by -3.37%, over one month by -8.35%, over three months by +16.56% and over the past year by -59.50%.
As of December 30, 2024, the stock is trading at USD 3.73 with a total of 1,411,056 shares traded.
Over the past week, the price has changed by -3.37%, over one month by -8.35%, over three months by +16.56% and over the past year by -59.50%.
Is Cardlytics a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cardlytics is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.70 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CDLX as of December 2024 is 2.07. This means that CDLX is currently overvalued and has a potential downside of -44.5%.
Neither. Based on ValueRay Fundamental Analyses, Cardlytics is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.70 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CDLX as of December 2024 is 2.07. This means that CDLX is currently overvalued and has a potential downside of -44.5%.
Is CDLX a buy, sell or hold?
Cardlytics has received a consensus analysts rating of 2.83. Therefor, it is recommend to hold CDLX.
Cardlytics has received a consensus analysts rating of 2.83. Therefor, it is recommend to hold CDLX.
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecast for CDLX stock price target?
According to ValueRays Forecast Model, CDLX Cardlytics will be worth about 2.4 in December 2025. The stock is currently trading at 3.73. This means that the stock has a potential downside of -35.12%.
According to ValueRays Forecast Model, CDLX Cardlytics will be worth about 2.4 in December 2025. The stock is currently trading at 3.73. This means that the stock has a potential downside of -35.12%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 4.4 | 18% |
| Analysts Target Price | 17 | 355.8% |
| ValueRay Target Price | 2.4 | -35.1% |